| Market Cap | 38.06M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -18.55M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -42.00% |
| Sales | 26.73M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -65.00% |
| Dividend | N/A | Price/Book | 0.14 | EPS next 5Y | - | 52W High Chg | -86.00% |
| Recommedations | - | Quick Ratio | 1.25 | Shares Outstanding | 23.65M | 52W Low Chg | 5.00% |
| Insider Own | 8.80% | ROA | -5.65% | Shares Float | 3.33M | Beta | 1.67 |
| Inst Own | 0.03% | ROE | -50.22% | Shares Shorted/Prior | 2.09M/1.76M | Price | 1.75 |
| Gross Margin | 28.27% | Profit Margin | -69.41% | Avg. Volume | 33,786 | Target Price | - |
| Oper. Margin | -13.51% | Earnings Date | - | Volume | 30,772 | Change | -3.85% |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.